The PROSPECT trial compared FOLFOX chemotherapy with the selective use of a radiotherapy intervention to chemoradiation for neoadjuvant treatment prior to surgery for locally advanced rectal cancer. Results were presented by Schrag et al at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract LBA2).
Question 1 of 5
What was the main finding of the PROSPECT study in patients with locally advanced rectal cancer?
